 Pfizer Inc NYSE: PFE has executed a definitive merger agreement with Global Blood Therapeutics Inc NASDAQ: GBT, whereby Pfizer will acquire the biopharmaceutical corporation dedicated to the delivery, development and discovery of life-changing medical treatment, Global Blood Therapeutics, for 5.4 billion, representing 68.50 per GBT share. 